eFFECTOR Therapeutics- Units (1 Ord Share Class A & 1/3 War) Common Stock

eFFECTOR Therapeutics- Units (1 Ord Share Class A & 1/3 War) (LWACU) currently reports a common stock of $220M as of June 2026. That compares with $220M in the prior-year period — up 3.8% year over year. Use the charts on this page to explore eFFECTOR Therapeutics- Units (1 Ord Share Class A & 1/3 War)'s common stock history and peer comparisons.

eFFECTOR Therapeutics- Units (1 Ord Share Class A & 1/3 War)'s common stock increased from $220M to $220M — a 3.8% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

eFFECTOR Therapeutics- Units (1 Ord Share Class A & 1/3 War) reported $220M in common stock as of June 2026. That compares with $220M in the prior-year period — up 3.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current common stock of $220M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for eFFECTOR Therapeutics- Units (1 Ord Share Class A & 1/3 War), and consider following LWACU for alerts when major investors trade the stock.

eFFECTOR Therapeutics- Units (1 Ord Share Class A & 1/3 War) is classified in the Healthcare sector. On common stock, it currently shows $220M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing LWACU with unrelated industries.